George Horvath
Title: Assistant Professor
Office: Room 230 C. Blake McDowell Law Building
Phone: 330-972-4990
Email: ghorvath@uakron.edu
Biography
George Horvath joined the Akron Law faculty as an Assistant Professor of Law in 2020. His scholarship combines his background as a practicing physician and medical scholar with empirical and doctrinal legal analysis to study the fraught intersections of law and health care. His work examines the ways in which statutory, regulatory, and implementation choices about the FDA’s role in regulating medical devices and drugs has impacted safety and innovation. His work also explores the ways in which multiple regulatory systems function together to create “emergent” regulatory systems whose effects on medical products are often quite different from those of any one system. Professor Horvath has been selected as a St. Louis University/American Society of Law, Medicine and Ethics Health Law Scholar (2022), a Loyola Chicago Wiet Life Sciences Law Scholar (2017, 2019, 2021, 2022), and an American Association of Law Schools Section on Law, Medicine, and Health Care New Voice in Health Law (2022).
Professor Horvath teaches Health Law, FDA Law, Civil Rights Law and Access to Health Care, and Torts. He serves as the Faculty Advisor for the Akron Law Health Law Society.
Prior to joining the Akron Law faculty, Professor Horvath was a postdoctoral Fellow in Public Law at the University of California, Berkeley, School of Law. He clerked for Judge John T. Noonan, Jr. on the Ninth Circuit Court of Appeals. Professor Horvath earned his J.D. at Berkeley Law, where he served as Editor-in-Chief of the California Law Review. Prior to his legal career, Professor Horvath earned his M.D. at Temple University Medical School and practiced as a cardiologist specializing in the treatment of heart rhythm disorders. He authored or co-authored over twenty articles that were published in the Journal of the American College of Cardiology, Circulation, Archives of Internal Medicine, and other medical journals.
Publications
Empirically Assessing 510(k) Device Safety, 62 Jurimetrics 113 (2023)
Evolution or Revolution in Telehealth Regulation? (invited response), 9 Texas A&M L. Rev. Arguendo 1 (2021)
Severability as Deregulation: The Construction of a New Doctrine Through Affordable Care Act Litigation, 15 Charleston L. Rev. 123 (2020)
Off-Label Drug Risks: Toward a New FDA Regulatory Approach, 29 Annals of Health Law 101 (2020) (available at )
Emergent Regulatory Systems and Their Challenges: The Case of Combination Medical Products, 94 Wash. L. Rev. 1697 (2019)
The Fair Deal Universal Health Care Proposals: Historians’ Perspectives from 1970 to 2003, 83 Albany L. Rev. 0501 (2019) (available at
Federal District Court Decisions on the Admissibility of Expert Witness Testimony: Revising the Conventional Narrative, 88 U. Cinn. L. Rev. 515 (2019) (available at )
Trading Safety for Innovation and Access: An Empirical Evaluation of the FDA’s Premarket Approval Process, 2017 BYU L. Rev. 991 (2017) (available at )
Recovery and Preemption: The Collision of the Medicare Secondary Payer Act and the Medical Device Amendments, 103 Calif. L. Rev. 1353 (2015) (Comment) (available at )